EPO and cerebral palsy: Razak and Hussain [29] have showed that the use of EPO in neonates with perinatal hypoxic-ischemic encephalopathy may reduce the risk of mortality, cerebral palsy, cognitive impairment, and brain injury in meta-analysis.